These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6520506

  • 1. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S, Nakanishi A, Noda T, Ando Y, Kamamoto Y, Moriyama I, Ichijo M.
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug 20; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H, Masuda T, Hattori A, Noguchi M, Ito Y, Nakanishi M, Ishihara M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep 20; 37(9):1883-92. PubMed ID: 2997349
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
    Ueda M, Sudo N, Furuya M, Arakawa O, Ikarashi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov 20; 37(11):2361-8. PubMed ID: 3001201
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R, Caffier H, Horner G, Lang K, Filbry E.
    Cancer Detect Prev; 1985 Nov 20; 8(1-2):115-20. PubMed ID: 4064031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y, Furuno K, Sano Y, Hirata T, Utsunomiya A, Nakajima H, Okabe K, Shimizu K, Akiya K, Fujiwara Y.
    Gan No Rinsho; 1985 May 20; 31(6 Suppl):655-63. PubMed ID: 2993692
    [Abstract] [Full Text] [Related]

  • 13. [Distribution and prognostic value of CEA and TPA in cancer of the lung].
    Leonardo E, Dogliotti C, Mancuso M, Sanfilippo B, Oliaro A.
    Minerva Med; 1986 Mar 17; 77(11):375-9. PubMed ID: 3703330
    [Abstract] [Full Text] [Related]

  • 14. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
    Sakamoto S, Kawana H, Shimizu K, Ishihara T, Ueda K, Usman SM, Uchida S, Kawagoe K, Kihara K, Kubo H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug 17; 36(8):1261-2. PubMed ID: 6595322
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A, Facchini V, Bartolini T, Fioretti P.
    Ann Ostet Ginecol Med Perinat; 1988 Aug 17; 109(3):151-5. PubMed ID: 3207319
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y, Ogawa K, Matsumoto N, Hosokawa T, Kikuchi T, Koyama N, Haga S, Kajiwara T, Sakakibara N.
    Gan No Rinsho; 1987 Aug 17; 33(10):1274-80. PubMed ID: 2444727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.